The Exchange

Commentary and Observations from
the Medical Front Lines

Lawrence Herman, PA-C, MPA

Lawrence Herman, PA-C, MPA

  • Clinical Associate Professor
  • University of South Carolina School of Medicine
  • Department of Family Medicine
  • Department of PA Studies
  • Columbia, South Carolina
COVID-19 Expands PA/NP Autonomy…and Scope of Practice for Other Professions, Too

COVID-19 Expands PA/NP Autonomy…and Scope of Practice for Other Professions, Too

The COVID-19 pandemic has been but one justification for expanding PA and NP autonomy in some states. In New York, Governor Andrew Cuomo's Executive Order 202.43 allowing autonomous advanced practice provider practice has impacted more than 13,526 PAsmore PAs than are licensed in any other state. This is, in my opinion, a good thing.

But the same pandemic has been utilized as leverage to permit and expand new areas of practice for others, too. These other... Continue Reading

Filed under: Health Policy and Trends, Practice Management/Career

Would You Volunteer to Enroll in a COVID-19 Vaccine Trial?

Would You Volunteer to Enroll in a COVID-19 Vaccine Trial?

There are more than 160 COVID-19 vaccines currently in development, with the University of Oxford/AstraZeneca AZD1222 vaccine (an attenuated altered adenovir... Continue Reading

Filed under: Allergy/Immunology, Infectious Diseases, Public Health

<em>JAMA Internal Medicine</em> Retracts Well-Publicized Paper

JAMA Internal Medicine Retracts Well-Publicized Paper

In what was then considered a very significant finding, JAMA Internal Medicine published an article in 2018 entitled "Association Betwe... Continue Reading

Filed under: Practice Management/Career

World Health Organization Halts Hydroxychloroquine Trial

World Health Organization Halts Hydroxychloroquine Trial

The World Health Organization (WHO) is but another organization to halt a COVID-19 therapeutic trial due to safety concerns. Specifically, WHO suspended the... Continue Reading

Filed under: Health Policy and Trends, Infectious Diseases

Upside Down: Influenza B Appears to be Waning While Influenza A is Increasing

Upside Down: Influenza B Appears to be Waning While Influenza A is Increasing

In a typical flu season, influenza A activity begins between November and January and fades after a few months. Concurrently, influenza B occurs with increas... Continue Reading

Filed under: Infectious Diseases, Public Health

You're Darned if You Do, You're Damned if You Don't

You're Darned if You Do, You're Damned if You Don't

Sorry, but I believe we are past the point of being worried about scaring people about the novel coronavirus 2019, now simply COVID-19 (in various forms of c... Continue Reading

Filed under: Health Policy and Trends, Infectious Diseases, Public Health

Influenza-like Illness Activity Has Been High for Weeks…and Continues to Increase

Influenza-like Illness Activity Has Been High for Weeks…and Continues to Increase

The CDC reports that influenza-like illness activity has been high for weeks, and is continuing to increase. Combined with the fact that influenza B (Victori... Continue Reading

Filed under: Infectious Diseases, Public Health

Mistakes in the Ambulatory Care Setting

Mistakes in the Ambulatory Care Setting

A report published in late October entitled "Deep Dive: Safe Ambulatory Care, Strategies for Patient Safety and Risk Reduction" Continue Reading

Filed under: Health Policy and Trends, Practice Management/Career, Public Health

November is Diabetes Awareness Month

November is Diabetes Awareness Month

Along with the colder weather and the promise of holiday season, November brings us the opportunity to raise awareness about diabetes. Both type 1 and type 2... Continue Reading

Filed under: Cardiometabolic, NPs & PAs, Practice Management/Career, Preventive Medicine, Public Health

Trans Fatty Acids Now Also Linked to Higher Risk of Dementia

Trans Fatty Acids Now Also Linked to Higher Risk of Dementia

Consumption of trans fats in high levels has been linked to coronary artery disease, diabetes and more. Now, a team of Japanese researchers have specifically... Continue Reading

Filed under: Cardiometabolic, Neurology, Preventive Medicine

FDA Approves First Oral GLP-1 RA

FDA Approves First Oral GLP-1 RA

The US Food and Drug Administration has approved semaglutide (Rybelsus, Novo Nordisk) as the first oral glucagon-like peptide receptor agonist (GLP-1 RA)&mda... Continue Reading

Filed under: Miscellaneous

Development Widget